Advanced genetic testing of embryos before transfer to improve IVF success and reduce risks.
Book AppointmentPre–Implantation Genetic Screening (PGS) is a laboratory technique used during IVF to examine embryos for chromosomal abnormalities before implantation. This ensures that only genetically healthy embryos are transferred to the uterus.
It is especially helpful for couples with recurrent IVF failures, miscarriages, or advanced maternal age.
Ensures only chromosomally normal embryos are selected.
Increases the chances of pregnancy and reduces miscarriage risk.
Performed by embryologists with cutting-edge genetic tools.
The process involves genetic testing of embryo cells before they are transferred to the uterus.
Embryos are developed in the IVF lab up to day 5 (blastocyst stage).
A few cells are carefully removed from the embryo for testing.
DNA is analyzed to check for chromosomal abnormalities.
Only healthy embryos are transferred to maximize success.
PGS helps improve IVF outcomes and ensures a healthier start to pregnancy.
Yes, it is safe and performed by embryologists in advanced IVF labs.
Couples with repeated IVF failures, miscarriages, or women above 35 years.
No, but it greatly improves success chances by selecting healthy embryos.
No, it is advised only in selected cases after doctor’s evaluation.
Share your details and our IVF team will connect with you.
.png){kind=icon}
.png){kind=icon}
